VIEWPOINTS PharmaShots Interview: Trialbee’s Matt Walz Shares Insight on Trialbee Honey PlatformBySenior EditorDecember 22, 20210Comments
VIEWPOINTS PharmaShots Interview: QIAGEN’s Anthony Ho Shares Insight on the US Government Contract to Boost the Production of PCR Tests for NeuMoDx SystemsBySenior EditorDecember 21, 20210Comments
VIEWPOINTS PharmaShots Interview: Boston Scientific’s Meghan Scanlon Shares Insight on the Completion of its $1.07B Lumenis AcquisitionBySenior EditorDecember 20, 20210Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in November 2021BySenior EditorDecember 16, 20210Comments
VIEWPOINTS PharmaShots Interview: Amolyt Pharma’s Thierry Abribat Shares Insight on the Data of AZP-3601 for HypoparathyroidismBySenior EditorDecember 15, 20210Comments
VIEWPOINTS PharmaShots Interview: Abbott’s Neil Moat Shares Insight on the US FDA’s Approval of Epic Plus Tissue Valves for Mitral or Aortic Valve ReplacementBySenior EditorDecember 14, 20210Comments
VIEWPOINTS PharmaShots Interview: AstraZeneca’s Alexander Bedenkov Shares Insight on First Virtual Events with Slush to Improve Patients OutcomesBySenior EditorDecember 13, 20210Comments
VIEWPOINTS PharmaShots Interview: Entasis Therapeutics’s Manos Perros Shares Insight on the Data of Sulbactam-Durlobactam (SUL-DUR) for Carbapenem-Resistant Acinetobacter InfectionsBySenior EditorDecember 9, 20210Comments
VIEWPOINTS PharmaShots Interview: TFF Pharmaceuticals’s Glenn Mattes Shares Insights on the Thin Film Freezing TechnologyBySenior EditorDecember 8, 20210Comments
